Medullary thyroid cancer laboratory findings
Jump to navigation
Jump to search
Medullary thyroid cancer Microchapters |
Differentiating Medullary thyroid cancer from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Medullary thyroid cancer laboratory findings On the Web |
American Roentgen Ray Society Images of Medullary thyroid cancer laboratory findings |
Risk calculators and risk factors for Medullary thyroid cancer laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Laboratory findings consistent with the diagnosis of medullary thyroid cancer include decreased thyroid stimulating hormone, elevated calcitonin, and decreased calcium.
Laboratory Findings
- Blood or imaging tests may be done prior to or in lieu of a biopsy. The following blood tests are conducted:
- Thyroid stimulating hormone (TSH)
- Thyroxine (T4)
- Triiodothyronine (T3)
- Calcitonin- Calcitonin is required for the diagnosis and follow up of medullary thyroid cancer. It is an important tumor marker.
- Carcinoembryonic antigen
- Tests for serum thyroid autoantibodies are done to rule out autoimmune thyroid disease.
- Laboratory findings consistent with the diagnosis of multiple endocrine neoplasia type 2 are tabulated below.
Test | Findings |
---|---|
Metabolic | Decreased thyroid stimulating hormone Antithyroid antibodies Elevated calcitonin Decreased calcium |
Adapted from Arzu Tatlıpınar1 and İlkay Kartal [Updated 2015].The Evaluation of Thyroid Nodules. Journal of Thyroid Disorders & Therapy.2015.[1] |
References
|